Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 7/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 3/20 | 0.47 |
| ▸ | TLR8 | Q9NR97 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9131395 | 0.90 | CYP1A2 (0.50) | TRPV1CYP1A2TLR8MAPTLMNA | |
| SCHEMBL29919709 | 0.76 | APP (0.53) | CYP1A2ELANEPOLB | |
| SCHEMBL10662377 | 0.76 | APP (0.53) | CYP1A2ELANEPOLB | |
| Acridine SCHEMBL8577853 | 0.74 | ALDH1A1 (0.58) | ELANETLR8MAPT | |
| SCHEMBL6114503 | 0.73 | PDE10A (0.60) | TRPV1CYP1A2TLR8LMNAPOLB | |
| SCHEMBL1253866 | 0.73 | CYP1A2 (0.59) | CYP1A2MAPTRAB9APDGFRBPDGFRA | |
| Acridine SCHEMBL29014290 | 0.73 | ALDH1A1 (0.68) | TLR8MAPT | |
| SCHEMBL8664260 | 0.73 | ALDH1A1 (0.45) | MAPTPOLB | |
| SCHEMBL16836341 | 0.72 | RAB9A (0.57) | CYP1A2TLR8MAPTRAB9AHSD17B10 | |
| SCHEMBL859430 | 0.72 | TRPV1 (0.56) | TRPV1CYP1A2TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4019493-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | FUJIFILM Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| EP-4019494-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | FUJIFILM Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-20220144760-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | FUJIFILM CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220135517-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | FUJIFILM CORPORATION (JP) | 2022-05-05 | — | — | US | disclosed |
| WO-2021033504-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | 富士フイルム株式会社 | 2021-02-25 | — | — | WO | disclosed |
| WO-2021033505-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | 富士フイルム株式会社 | 2021-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135517-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | PARG, PTGIS, MT-ATP8 | TRPV1 175/4885CYP1A2 841/4885ELANE 4791/4885 |
| US-20220144760-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | NOXO1, MT-CO2, MT-ATP8 | TRPV1 121/4885CYP1A2 619/4885ELANE 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.